PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial | Trials | Full Text
Suggested Treatment Algorithms for the Management of ... | GrepMed
An update on polymyalgia rheumatica - Lundberg - 2022 - Journal of Internal Medicine - Wiley Online Library
Prednisone Withdrawal: Symptoms, What to Expect, and More
The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
PDF] Induction of Remission is Difficult due to Frequent Relapse during Tapering Steroids in Korean Patients with Polymyalgia Rheumatica | Semantic Scholar
Polymyalgia Rheumatica & Giant-cell Arteritis - ppt video online download
Case Report: The Hairdresser Who Couldn't Comb Hair - The Rheumatologist
Polymyalgia rheumatica | The BMJ
JKMS :: Journal of Korean Medical Science
Taper schedule for steroids (dose in mg) | Download Table
Taper schedule for steroids (dose in mg) | Download Table
Tocilizumab improves GCA outcomes in patients with polymyalgia, cranial symptoms
Characteristics of Giant Cell Arteritis Flares After Successful Treatment with Tocilizumab: Results from the Long-Term Extension of a Randomized Controlled Phase 3 Trial - ACR Meeting Abstracts
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial - The Lancet
Giant-Cell Arteritis and Polymyalgia Rheumatica | NEJM